# Cardiorenal Risk Stratification Pilot Study

> **NCT03628443** · — · UNKNOWN · sponsor: **Coney Island Hospital, Brooklyn, NY** · enrollment: 100 (estimated)

## Conditions studied

- Cardio-Renal Syndrome
- Heart Failure
- Chronic Kidney Diseases

## Interventions

- **DIAGNOSTIC_TEST:** Fibroblast Growth Factor 23

## Key facts

- **NCT ID:** NCT03628443
- **Lead sponsor:** Coney Island Hospital, Brooklyn, NY
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-19
- **Primary completion:** 2019-10-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03628443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03628443, "Cardiorenal Risk Stratification Pilot Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03628443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*